The paper details a study investigating the distinct ways glioblastoma (GBM) tumors metabolize glucose compared to healthy brain tissue. Using stable isotope tracing in human patients and mice, the researchers determined that while the cortex uses glucose primarily for physiological functions like the TCA cycle and neurotransmitter synthesis, aggressive GBM redirects glucose-derived carbons to produce nucleotides and NAD/NADH to support proliferation and invasion. Crucially, the study identifies that many gliomas prioritize environmental serine uptake over glucose-driven synthesis, a metabolic vulnerability that can be exploited, as restricting dietary serine/glycine was shown to slow tumor growth and enhance the efficacy of standard chemoradiation treatment. These findings uncover a key metabolic difference in brain cancer that suggests novel strategies for targeted therapy, potentially paving the way for precision dietary interventions to improve GBM outcomes.

References:

• Scott A J, Mittal A, Meghdadi B, et al. Rewiring of cortical glucose metabolism fuels human brain cancer growth[J]. Nature, 2025: 1-10.